(Q54084104)

24 May 2018

title

Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: Preliminary results of an open French multicentre randomized study (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

28 November 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

28 November 2022

author name string

A. Broustet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

J. Reiffers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

G. Marit

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

D. Fiere

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

J. Jaubert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

J. Reynaud

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

J. Pris

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

P. Bernard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

C. Charrin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

Z. Q. Wen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799467

28 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1799467

28 November 2022

publication date

1 January 1991

1 reference

24 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:027753799190558U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

https://api.elsevier.com/content/article/PII:027753799190558U?httpAccept=text/plain

28 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

European Journal of Cancer

28 November 2022

published in

1 reference

24 May 2018

volume

27 Suppl 4

1 reference

24 May 2018

page(s)

S18-21

1 reference

24 May 2018

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

Staging of chronic myeloid leukaemia

28 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia

28 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

Psychiatric complications of long-term interferon alfa therapy

28 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCER

28 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90558-U

28 November 2022

Identifiers

0 references

1 reference

24 May 2018